According to our results, XB130 level elevated in prostate cancer tissues when compared with adjacent tissues and 85.6% specimen shows positive staining, which suggests that XB130 could be a candidate marker assisting diagnosis of prostate cancer. This evidence concerns the gene AFAP1L2 and prostate cancer.